Oncomatryx at the “Cancer Metabolism and the Tumour Microenvironment Conference”.
9-12, November. Paphos, Cyprus.
Myriam Fabre, PhD. (Oncomatryx R&D Director) will attend the conference as speaker:
TARGETING TUMOR MICROENVIRONMENT TO TREAT INVASIVE TUMORS: OMTX705, A POWERFUL FAP-SPECIFIC ANTIBODY-DRUG CONJUGATE.
If you are also attending the conference and would like to meet us please fill this form to arrange an appointment.